2013
DOI: 10.1074/jbc.m113.495549
|View full text |Cite
|
Sign up to set email alerts
|

Mechanism and Regulation of Mycobactin Fatty Acyl-AMP Ligase FadD33

Abstract: Background: Fatty acyl-AMP ligase FadD33 is required for mycobactin biosynthesis. Results: FadD33 catalyzes a two-step kinetic mechanism, and FadD33 activity is regulated by post-translational acetylation. Conclusion: Mycobactin FadD33 activity is reversibly regulated by Pat (acetylation) and DAc1 (deacetylation). Significant: Post-translational regulation via acetylation of enzymes can modulate siderophore biosynthesis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
39
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 38 publications
(42 citation statements)
references
References 39 publications
3
39
0
Order By: Relevance
“…In M. tuberculosis , this situation is relevant after engulfment by human macrophages, where the organism maintains its metabolic equilibrium using host fatty acids and cholesterol (19). There are other fatty acyl synthetases that are similarly regulated in M. tuberculosis , including the fatty acyl synthetase implicated in mycobactin biosynthesis (20). Mycobacterium tuberculosis thus has evolved posttranslational modification, specifically enzyme acetylation, to adapt its metabolic activity to the various environments that it encounters and survives.…”
Section: Resultsmentioning
confidence: 99%
“…In M. tuberculosis , this situation is relevant after engulfment by human macrophages, where the organism maintains its metabolic equilibrium using host fatty acids and cholesterol (19). There are other fatty acyl synthetases that are similarly regulated in M. tuberculosis , including the fatty acyl synthetase implicated in mycobactin biosynthesis (20). Mycobacterium tuberculosis thus has evolved posttranslational modification, specifically enzyme acetylation, to adapt its metabolic activity to the various environments that it encounters and survives.…”
Section: Resultsmentioning
confidence: 99%
“…Mutation of the biochemical machinery responsible for mycobactin biosynthesis inhibits M. tuberculosis growth whilst preventing the establishment of infection . Inhibitors for several enzymes in the mycobactin biosynthetic pathway have been investigated; however, of these targets, MbtA, which catalyses the condensation reaction between salicylate and an aroyl acyl carrier protein via a salicyl‐AMP intermediate ( 387 ), has been the most extensively and successfully exploited and has no mammalian homologues. Ferreras et al.…”
Section: Tuberculosismentioning
confidence: 99%
“…Activated M. tuberculosis Pat acetylates and inhibits the activity of multiple downstream enzymes such as ACS, fatty acyl-CoA ligase FadD13, and fatty acyl-AMP ligase FadD33, which regulate fatty acid metabolism and siderophore biosynthesis, respectively. 140,145,146 …”
Section: Proteinsmentioning
confidence: 99%